Csl Limited Stock Profit Margin

CMXHF Stock  USD 173.50  0.90  0.52%   
CSL Limited fundamentals help investors to digest information that contributes to CSL's financial success or failures. It also enables traders to predict the movement of CSL Pink Sheet. The fundamental analysis module provides a way to measure CSL's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CSL pink sheet.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

CSL Limited Company Profit Margin Analysis

CSL's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.

Profit Margin

 = 

Net Income

Revenue

X

100

More About Profit Margin | All Equity Analysis

Current CSL Profit Margin

    
  0.21 %  
Most of CSL's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CSL Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Competition

Based on the latest financial disclosure, CSL Limited has a Profit Margin of 0.2135%. This is 101.9% lower than that of the Healthcare sector and 100.93% lower than that of the Biotechnology industry. The profit margin for all United States stocks is 116.81% lower than that of the firm.

Did you try this?

Run Equity Analysis Now

   

Equity Analysis

Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
All  Next Launch Module

CSL Fundamentals

About CSL Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze CSL Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CSL using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CSL Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in CSL Pink Sheet

CSL financial ratios help investors to determine whether CSL Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CSL with respect to the benefits of owning CSL security.